Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00880750 · ClinicalTrials.gov registry record · Phase 1
Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults
A Phase 1 study, sponsored by Shire.
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT00880750 is a Phase 1 study that has completed, run by Shire. The registered enrollment target is 72 participants.
The verdict
NCT00880750, a Phase 1 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
This study is being conducted to assess any potential differences in the absorption and excretion between two lanthanum carbonate formulations. This study is also being done to assess the safety and tolerability of the two lanthanum carbonate formulations.
Interventions
- DRUG Lanthanum carbonate Granule Formulation
- DRUG Lanthanum carbonate Chewable Tablets (Fosrenol)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2009-01-28 |
| Est. Completion | 2009-06-22 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00880750
The ClinicalTrials.gov registry entry for NCT00880750 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lanthanum carbonate Granule Formulation is the first listed.
NCT00880750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00880750 about?
NCT00880750 is a clinical study titled "Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults". This study is being conducted to assess any potential differences in the absorption and excretion between two lanthanum carbonate formulations. This study is also being done to assess the safety and tolerability of the two lanthanum carbonate formulations.
What is the current status of trial NCT00880750?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2009-01-28. Estimated completion is 2009-06-22.
What interventions are being tested in trial NCT00880750?
The interventions under investigation include: Lanthanum carbonate Granule Formulation (DRUG), Lanthanum carbonate Chewable Tablets (Fosrenol) (DRUG).
Who is sponsoring clinical trial NCT00880750?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.